导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.66% | 176/1050 |
| 近一周 | -3.65% | 914/1104 |
| 近一月 | -4.45% | 550/1102 |
| 近一季 | -18.22% | 926/1092 |
| 近半年 | 19.83% | 143/1070 |
| 近一年 | 34.77% | 132/1018 |
| 近两年 | 130.04% | 123/926 |
| 近三年 | 139.73% | 64/834 |
| 成立以来 | 294.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.08% 489/1070 |
64.46% 164/1101 |
- - |
- - |
| 2025 | 71.43% 58/1065 |
2.80% 562/1014 |
5.76% 258/1038 |
47.32% 105/1050 |
7.03% 84/1065 |
| 2024 | 17.52% 123/1011 |
11.61% 16/960 |
5.44% 81/983 |
6.27% 850/991 |
-6.02% 735/1011 |
| 2023 | 16.30% 10/952 |
12.71% 71/880 |
2.10% 96/895 |
2.91% 21/915 |
-1.80% 215/952 |
| 2022 | 2.24% 11/867 |
-4.79% 32/773 |
1.18% 675/806 |
2.65% 8/845 |
3.40% 266/867 |
| 2021 | 8.43% 267/740 |
5.93% 41/580 |
0.76% 536/659 |
0.38% 209/704 |
1.20% 388/740 |
| 2020 | 23.69% 374/554 |
-6.76% 335/419 |
14.76% 357/466 |
11.61% 212/517 |
3.56% 457/554 |
| 2019 | 20.62% 330/410 |
10.87% 1045/1149 |
3.45% 92/1231 |
0.53% 323/390 |
4.62% 350/410 |
| 2018 | -12.42% 15/349 |
- - |
- - |
- - |
-1.88% 28/1080 |
| 2017 | 30.61% 39/285 |
- - |
- - |
- - |
- - |
| 2016 | -1.47% 31/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 景顺长城沪港深精选股票A VS. 东吴新产业精选股票A(580008) |